Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Toxic Shock Syndrome”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Testing effectiveness (Phase 2)Study completedNCT02814708
What this trial is testing

Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults

Who this might be right for
Toxic Shock Syndrome
Biomedizinische Forschungs gmbH 140
Not applicableStudy completedNCT05036603
What this trial is testing

Comparison of the Acute Effects of Chest Physiotherapy Methods Applied in Different Positions in Preterm Newborns

Who this might be right for
Preterm BirthPrematureBronchopulmonary Dysplasia+10 more
Sanko University 60
Testing effectiveness (Phase 2)Study completedNCT02219165
What this trial is testing

Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot Study

Who this might be right for
Toxic Shock Syndrome
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Looking for participantsNCT05972135
What this trial is testing

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 100
Early research (Phase 1)Study completedNCT02340338
What this trial is testing

RTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Who this might be right for
Toxic Shock SyndromeVaccination; Sepsis
Biomedizinische Forschungs gmbH 46
Not applicableUnknownNCT06126263
What this trial is testing

Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections

Who this might be right for
Streptococcal SepsisInvasive Group A Beta-Haemolytic Streptococcal DiseaseNecrotizing Soft Tissue Infection+3 more
National Institutes of Health Clinical Center (CC) 1,000
Post-approval studies (Phase 4)WithdrawnNCT02899702
What this trial is testing

Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children

Who this might be right for
Staphylococcal InfectionStreptococcal Infection
Hospices Civils de Lyon
Not applicableStudy completedNCT02848144
What this trial is testing

Pediatric Immune Response to Infectious Shock

Who this might be right for
Severe Pediatric Infectious Shock
Hospices Civils de Lyon 105
Not applicableEnrolling By InvitationNCT07499128
What this trial is testing

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Who this might be right for
Cytokine Release SyndromeNeoplasmsLymphoma+13 more
National Cancer Institute (NCI) 136
Post-approval studies (Phase 4)WithdrawnNCT01374061
What this trial is testing

Pre Hospital Evaluation of Video Laryngoscopy

Who this might be right for
Cardiac ArrestRespiratory Distress SyndromeShock+3 more
Assistance Publique - Hôpitaux de Paris
Large-scale testing (Phase 3)Study completedNCT00358501
What this trial is testing

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Who this might be right for
Severe Hepatic Veno-Occlusive Disease
Jazz Pharmaceuticals 134
Early research (Phase 1)Study completedNCT02971670
What this trial is testing

Amendment of rTSST-1 Variant Vaccine Phase 1 Clinical Trial

Who this might be right for
Toxic-Shock SyndromeSepsis
Biomedizinische Forschungs gmbH 23
Early research (Phase 1)Study completedNCT00974935
What this trial is testing

Phase I STEBVax in Healthy Adults

Who this might be right for
Toxic Shock Syndrome Staphylococcal
National Institute of Allergy and Infectious Diseases (NIAID) 29
Testing effectiveness (Phase 2)WithdrawnNCT06703216
What this trial is testing

Pre-emptive Anakinra for Cytokine Event Reduction

Who this might be right for
B-Acute Lymphoblastic LeukemiaCAR-T Cell TherapyCytokine Release Syndrome+2 more
Kevin McNerney
Not applicableLooking for participantsNCT06226441
What this trial is testing

Aminoglycoside Administration in Septic Patients

Who this might be right for
SepsisSeptic ShockAminoglycoside Toxicity+1 more
University of Thessaly 50
Not applicableLooking for participantsNCT07199998
What this trial is testing

Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota

Who this might be right for
Sexual Transmitted DiseaseVaginosis, BacterialMycosis+5 more
Centre National de la Recherche Scientifique, France 300
Not applicableLooking for participantsNCT06124599
What this trial is testing

Prodromes of Menstrual Staphylococcal Toxic Shock

Who this might be right for
Toxic Shock Syndrome Staphylococcal
Hospices Civils de Lyon 316
Early research (Phase 1)Study completedNCT00027144
What this trial is testing

Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase

Who this might be right for
Leukemia,Myeloid, ChronicLeukemia,Myeloid,Philadelphia-Positive
University of Connecticut 10
Large-scale testing (Phase 3)Study completedNCT05208242
What this trial is testing

Strong Albumin Solutions in Patients With Septic Shock

Who this might be right for
SepsisSeptic ShockShock, Toxic
Manchester University NHS Foundation Trust 47
Early research (Phase 1)Looking for participantsNCT07169487
What this trial is testing

Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study

Who this might be right for
Cytokine Release SyndromeICANS
Institute of Hematology & Blood Diseases Hospital, China 18
Next Page